Low Relapse Rate Leads to High Concordance of Sustained Virologic Response (SVR) at 12 Weeks With SVR at 24 Weeks After Treatment With ABT-450/Ritonavir, Ombitasvir, and Dasabuvir Plus Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection in the AVIATOR Study
Keyword(s):
2017 ◽
Vol 185
(2)
◽
pp. 484-493
◽
2018 ◽
Vol 73
◽
pp. 376
Keyword(s):
2017 ◽
Vol 66
(1)
◽
pp. S3-S4
◽
2017 ◽
Vol 66
(1)
◽
pp. S519-S520
◽
Keyword(s):
Keyword(s):